Microplastics Invade Human Blood and Lungs

Microplastics invade human blood, lungs, placenta, and even arterial plaques, fueling a silent epidemic of inflammation and chronic disease that functional medicine now targets with proactive detox protocols.

Story Snapshot

Humans ingest a credit card’s worth of microplastics weekly through food, air, water, and skin.
Functional medicine shifts from alarmism to clinical action: test biomarkers like oxidative stress and inflammation, then support liver and gut detox.
2024 NEJM study links microplastics in artery plaques to cardiovascular events, confirming internal threats.
Protocols emphasize resilience-building over impossible particle removal, bridging research to patient care.
Leaders like Mark Hyman, MD, empower practitioners with personalized strategies against this ubiquitous toxin.

Microplastics Enter Human Bodies

Particles smaller than 5mm surged from 1950s plastic production. Humans absorb them via food packaging, bottled water, airborne dust, and personal care products. A 2019 Australian study calculated weekly intake equivalent to a credit card’s weight. Liver processes these invaders, gut translocates them into bloodstream, triggering endocrine disruption. Detections escalated: blood in 2022, lungs and placenta by 2023.

Scientific Confirmations Escalate Alarm

Researchers found microplastics in every human tissue sampled post-2022. Lungs contain fibers from inhaled air. Placenta crossings threaten fetal development. The 2024 NEJM study identified them in arterial atheromas, associating higher loads with doubled cardiovascular event risk. Toxicology pins effects on inflammation, oxidative stress, and mitochondrial damage. No escape exists; polar ice melt promises worse airborne spread.

Functional Medicine Pioneers Protocols

Mark Hyman, MD, and Dr. Joseph Pizzorno lead with root-cause strategies. Clinics like Functional GYN, Richmond Functional Medicine, and IFM implement three-stage frameworks. First, assess via biomarkers: 8-OHdG for oxidative stress, hs-CRP for inflammation, zonulin for gut permeability, LPS for endotoxemia. Liver enzymes and hormone panels reveal disruptions. Personalized testing detects invisible burdens before symptoms strike.

Targeted Mitigation Strategies Emerge

Interventions fortify natural detox pathways. Liver support uses antioxidants like glutathione precursors and milk thistle. Gut restoration deploys L-glutamine, probiotics, and high-fiber diets to bind and excrete particles. Reduce exposure: filter water, avoid plastic heating, choose glass storage. Huberman Lab episodes detail excretion enhancers. Experimental options like therapeutic apheresis and microbial biodegradation show promise but lack standardization.

Health Impacts Demand Urgent Action

Short-term effects hit hard: inflammation drives obesity and PCOS; oxidative stress burdens liver. Long-term risks include CVD, cancer, autoimmunity via gut-mitochondrial sabotage. Pregnant women face placental transfer; CVD patients see plaque acceleration.